Work

Asciminib for newly diagnosed chronic myeloid leukemia: Results from A phase II trial

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5565

Authors: Fadi Haddad, Elias Jabbour, Ghayas Issa, Koji Sasaki, Rita Khouri, Alex Bataller, Jayastu Senapati, Tapan Kadia, Guillermo Montalban-Bravo, Naveen Pemmaraju, Anwesha Ray, Sara Dellasala, Hagop Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417023407

Cites:

Cited by:

Related to: